我要投票 Jinhe金河在饲料添加剂行业中的票数:86
· 外 推 电 报 ·
2025-02-06 13:14:03 星期四

【Jinhe金河是哪个国家的品牌?】

Jinhe金河是什么牌子?「Jinhe金河」是 金河生物科技股份有限公司 旗下著名品牌。该品牌发源于内蒙古,由创始人王东晓在1990期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

金河生物科技股份有限公司是一家生产和销售饲用金霉素及动物保健品为主的民营控股企业,1998年被国家科委认定为“国家重点高新技术企业”,同时也是内蒙古自治区60家重点企业之一。

公司位于青山南麓、黄河之滨的内蒙古托克托县境内,与亚洲最大的火力发电厂——大唐托克托电厂比邻相依,并与中国最大的露天煤矿——准格尔煤田隔(黄)河相望,具有得天独厚的地理优势和资源优势。

公司现拥有国际上先进的发酵生产设备和产品质量检测设备,主要工艺流程全部采用微机自动控制,现有发酵吨位5794立方米,金霉素的发酵规模居世界前列。

其主导产品“牧星”、“金河”牌饲用金霉素目前年生产能力5.3万多吨,连续六次顺利通过美国联邦政府食品与药品管理总署(FDA)的质量验收。

产品主要出口到美国、加拿大、东南亚等国家和地区,同时行销网络遍布国内各省、市(自治区),市场前景十分广阔。

作为一家高新技术企业,金河生物科技股份有限公司近年来得到了迅猛的发展,这主要得益于企业以人为本的发展思路和强大的技术支撑。

通过人才的引进和人力资源的合理配置,使企业逐步形成了自己的人才梯队,在充分发挥人才优势的群体效应的同时,在生产技术领域不断地完善与创新,为企业在知识经济时代异军突起奠定了坚实的基础。

良好的信誉、卓越的品质源于企业严格的管理和对技术创新孜孜不倦的追求。

2001-2002年,企业先后顺利通过了ISO9002质量体系认证和国家兽药企业GMP验收。

从1994年起,企业连续六次顺利通过美国联邦政府食品药品管理总署(FDA)的质量验收,并被国家九部委认定为农业产业化国家重点龙头企业。

金河生物科技股份有限公司在未来的发展进程中,将按照“面向市场、优化结构、整合资源、提高效益”的发展构想,以发酵工业为载体,以调整产品结构为主线,走外延与内涵相结合扩大再生产的科技强企之路,通过与行业精英联盟,实现资产优化和管理升级,结合基因工程等高科技手段的探索与研究,全面提升企业的整体素质和核心竞争力,进一步增强企业的经济实力和发展后劲,为民族工业的繁荣和发展做出新的更大的贡献。

英文翻译:Jinhe Biotechnology Co., Ltd. is a private holding enterprise mainly engaged in the production and sale of feed chlortetracycline and animal health products. In 1998, it was recognized as a "national key high-tech enterprise" by the State Science and Technology Commission, and also one of the 60 key enterprises in Inner Mongolia Autonomous Region. The company is located in Tuoketuo County, Inner Mongolia, on the south foot of Qingshan mountain and the Bank of the Yellow River. It is adjacent to Datang Tuoketuo Power Plant, the largest thermal power plant in Asia, and across the (yellow) River from Jungar coal field, the largest open-pit coal mine in China. It has unique geographical advantages and resource advantages. The company now has advanced fermentation production equipment and product quality testing equipment in the world. The main technological process is all controlled by computer automatically. The current fermentation tonnage is 5794 cubic meters, and the fermentation scale of chlortetracycline ranks the top in the world. Its leading products "muxing" and "Jinhe" brand feed aureomycin currently have an annual production capacity of more than 53000 tons, and have successfully passed the quality acceptance of the United States Federal Food and Drug Administration (FDA) for six consecutive times. The products are mainly exported to the United States, Canada, Southeast Asia and other countries and regions. At the same time, the marketing network is all over the domestic provinces, cities (autonomous regions), and the market prospect is very broad. As a high-tech enterprise, Jinhe Biotechnology Co., Ltd. has developed rapidly in recent years, which is mainly due to the people-oriented development ideas and strong technical support of the enterprise. Through the introduction of talents and the rational allocation of human resources, the enterprise has gradually formed its own talent echelon. While giving full play to the group effect of talent advantages, it has constantly improved and innovated in the field of production technology, laying a solid foundation for the emergence of enterprises in the era of knowledge economy. Good reputation and excellent quality come from the strict management of the enterprise and the tireless pursuit of technological innovation. From 2001 to 2002, the company has successfully passed ISO9002 quality system certification and GMP acceptance of national veterinary drug enterprises. Since 1994, the company has successfully passed the quality acceptance of the United States Federal Food and Drug Administration (FDA) for six consecutive times, and has been recognized as the national key leading enterprise of agricultural industrialization by nine ministries and commissions. In the future development process, Jinhe Biotechnology Co., Ltd. will follow the development concept of "facing the market, optimizing the structure, integrating the resources and improving the efficiency", take the fermentation industry as the carrier, adjust the product structure as the main line, take the road of expanding the renewable production through the combination of extension and connotation, and realize the asset optimization and management upgrading through the alliance with the industry elite, Combined with the exploration and research of high-tech means such as genetic engineering, we will comprehensively improve the overall quality and core competitiveness of enterprises, further enhance the economic strength and development potential of enterprises, and make new and greater contributions to the prosperity and development of national industry.

本文链接: https://www.waitui.com/brand/cc6e5eebb.html 联系电话:0471-8511111

千城特选小程序码

7×24h 快讯

阿维塔申请阿维塔新豪华商标

36氪获悉,天眼查知识产权信息显示,近期,阿维塔科技(重庆)有限公司申请注册多枚“阿维塔新豪华”商标,国际分类涉及广告销售、教育娱乐、运输贮藏等,当前商标状态均为等待实质审查。

2小时前

麦格理据悉关闭美国债务资本市场部门,以专注于私人信贷

据彭博,知情人士透露,麦格理正关闭其美国债务资本市场部门,以将资源集中在私人信贷上。这位不愿透露姓名的知情人士表示,该公司在周三的员工大会上向员工传达这项决定,麦格理投资银行部门Macquarie Capital约80名员工将受到影响。他们表示,部分受影响的员工将被调往其他职位。知情人士表示,麦格理计划在未来两年内出售其通过美国债务资本市场活动累积的头寸,这将为私人信贷创造更多的资产负债表空间。(财联社)

2小时前

半日主力资金加仓电子、计算机股,抛售银行股

主力资金早间净流入电子、计算机、机械设备、非银金融等板块,净流出银行、农林牧渔、建筑材料、纺织服饰等板块。具体到个股来看,北方华创、每日互动、领益智造获净流入13.75亿元、13.23亿元、12.94亿元。净流出方面,华联股份、视觉中国、慈新股份遭抛售5.42亿元、5.05亿元、4.47亿元。(第一财经)

2小时前

日元兑美元升破152关口,日本央行委员称须及时逐步加息

随着日本央行公布委员田村直树的讲话稿,日元兑美元涨幅扩大,触及12月12日以来最高水平。10年期日本国债期货一度回吐涨幅。日元兑美元一度涨0.5%至151.82。田村直树表示,日本央行需要及时逐步加息,2025财年下半年利率水平达到1%应该在考虑之列。(新浪财经)

2小时前

终止与本田合并谈判后,日产据悉寻找新合作伙伴并把目光投向业外

据彭博,知情人士称,日产汽车准备结束与本田汽车组建一家联合控股公司的谈判,正在寻找新的合作伙伴,日产想找一个最好来自科技行业且总部在美国的合作伙伴。北美是日产最重要的市场,而且朝着电气化和自动化方向的全面转型促使全球汽车制造商寻求与其他行业结盟。一位知情人士说,本田提出了收购日产并成为其母公司的想法,但在日产内部遭到了强烈反对。这位知情人士补充说,投资水平也是一个卡点。(界面)

2小时前

本页详细列出关于Novozymes诺维信的品牌信息,含品牌所属公司介绍,Novozymes诺维信所处行业的品牌地位及优势。
咨询